GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 552.7
3 061.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GLAXO stock under the Base Case scenario is 1 129.69 INR. Compared to the current market price of 2 457.15 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 54%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
GlaxoSmithKline Pharmaceuticals Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GLAXO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
GlaxoSmithKline Pharmaceuticals Ltd
Balance Sheet Decomposition
GlaxoSmithKline Pharmaceuticals Ltd
Current Assets | 28B |
Cash & Short-Term Investments | 20.1B |
Receivables | 2.2B |
Other Current Assets | 5.7B |
Non-Current Assets | 7.6B |
Long-Term Investments | 111.4m |
PP&E | 3.1B |
Intangibles | 235.5m |
Other Non-Current Assets | 4.1B |
Current Liabilities | 15.2B |
Accounts Payable | 6.3B |
Other Current Liabilities | 9B |
Non-Current Liabilities | 2.5B |
Long-Term Debt | 64.7m |
Other Non-Current Liabilities | 2.5B |
Earnings Waterfall
GlaxoSmithKline Pharmaceuticals Ltd
Revenue
|
35.1B
INR
|
Cost of Revenue
|
-13.3B
INR
|
Gross Profit
|
21.7B
INR
|
Operating Expenses
|
-12.5B
INR
|
Operating Income
|
9.3B
INR
|
Other Expenses
|
-2.9B
INR
|
Net Income
|
6.4B
INR
|
Free Cash Flow Analysis
GlaxoSmithKline Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
GLAXO Profitability Score
Profitability Due Diligence
GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Score
GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
GLAXO Solvency Score
Solvency Due Diligence
GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for GLAXO is 2 966.93 INR with a low forecast of 2 646.2 INR and a high forecast of 3 412.5 INR.
Dividends
Current shareholder yield for GLAXO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
GLAXO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company is headquartered in Mumbai, Maharashtra and currently employs 3,840 full-time employees. The firm is engaged in the business of manufacturing, distributing, and trading in pharmaceuticals. The company manufactures medicinal substances used in the manufacture of pharmaceuticals, such as antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts, and esters; glycosides and vegetable alkaloids, and chemically pure sugar. The company offers a range of prescription medicines, vaccines, and consumer healthcare products. Its medicine portfolio includes Adartrel, Bactroban, Combodart, and Duodart. Its vaccines portfolio includes Ambirix, Cervarix, Fendrix, and Havrix. The Company’s products include Betamethasone, Potassium Clavulanate with Amoxycillin and Pneumococcal Polysaccharide and Conjugate Vaccine. Its oral health products include Sensodyne, parodontax and Polident. Its manufacturing unit is located at Nashik.
Contact
IPO
Employees
Officers
The intrinsic value of one GLAXO stock under the Base Case scenario is 1 129.69 INR.
Compared to the current market price of 2 457.15 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 54%.